Aug 16, 2018 | Featured Insights
Last week, Baron & Budd’s lawyers secured $90 million from AstraZeneca in a resolution that the pharmaceutical company targeted the Texas Medicaid system with a fraudulent marketing scheme for its expensive and powerful atypical antipsychotic drugs Seroquel IR and... 
Feb 14, 2018 | Featured Insights
Last week, a whistleblower claim was settled between a mental health services provider and the Commonwealth of Massachusetts for $4 million. The plaintiff, Christine Martino-Fleming, was a former Coordinator of Staff Development and Training at South Bay Mental...